X0206 3 2022-12-13 0 0001042418 Inhibitor Therapeutics, Inc. INTI 0001275857 MCNULTY JAMES A C/O INHIBITOR THERAPUTICS, INC., 900 WEST PLATT ST, SUITE 200 TAMPA FL 33606 0 1 1 0 See Remarks Common Stock 548000 D Common Stock 85627069 I See Footnotes Options 0.24 2016-07-01 2026-07-01 Common Stock 150000 D These shares represent 6,000,000 shares of common stock held by Hopkins Capital Group II, LLC ("HCG II LLC") and 79,627,069 shares of common stock held by Hedgepath, LLC ("HP LLC"). Mr. McNulty is the manager of HCG II LLC and HP LLC. As such, Mr. McNulty may be deemed to have beneficial ownership of the common stock held by HCG II LLC and HP LLC through his voting and dispositive control over HCG II LLC and HP LLC. Mr. McNulty disclaims any beneficial ownership of the reported shares held by HCG II LLC and HP LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly. Chief Financial Officer, Treasurer, Secretary of the Company /s/ James McNulty 2022-12-22